{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:26:50Z","timestamp":1790015210682,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007162","name":"Department of Science and Technology of Guangdong Province","doi-asserted-by":"publisher","award":["2023B1212010010"],"award-info":[{"award-number":["2023B1212010010"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.meegid.2024.105653","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:24:07Z","timestamp":1722903847000},"page":"105653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Hepatitis C virus subtype distribution and resistance-associated substitutions in high-risk population groups in Guangdong Province, China"],"prefix":"10.1016","volume":"123","author":[{"given":"Shilan","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guolong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinge","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bosheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.meegid.2024.105653_bb0005","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1053\/jhep.2001.24432","article-title":"Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity","volume":"33","author":"Adinolfi","year":"2001","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"2","key":"10.1016\/j.meegid.2024.105653_bb0010","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jmv.21680","article-title":"Geographic distribution of hepatitis C virus genotype 6 subtypes in Thailand","volume":"82","author":"Akkarathamrongsin","year":"2010","journal-title":"J. Med. Virol."},{"issue":"11","key":"10.1016\/j.meegid.2024.105653_bb0015","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/infdis\/jiy401","article-title":"Identification of a novel hepatitis C virus genotype from Punjab, India: expanding classification of hepatitis C virus into 8 genotypes","volume":"218","author":"Borgia","year":"2018","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.meegid.2024.105653_bb0020","article-title":"Hepatitis C virus genotypes and subtypes circulating in mainland China","volume":"6","author":"Chen","year":"2017","journal-title":"Emerg. Microbes Infect."},{"issue":"12","key":"10.1016\/j.meegid.2024.105653_bb0025","first-page":"1332","article-title":"Guidelines for the prevention and treatment of hepatitis C (2022 version)","volume":"30","author":"Chinese Society of Hepatology","year":"2022","journal-title":"Chin. J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.meegid.2024.105653_bb0030","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.gastro.2017.11.007","article-title":"Patterns of resistance-associated substitutions in patients with chronic HCV infection following treatment with direct-acting antivirals","volume":"154","author":"Dietz","year":"2018","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.meegid.2024.105653_bb0035","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.17323","article-title":"Serological assay and genotyping of hepatitis C virus in infected patients in Zanjan province","volume":"14","author":"Esmaeilzadeh","year":"2014","journal-title":"Hepat. Mon."},{"issue":"5","key":"10.1016\/j.meegid.2024.105653_bb0040","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: final update of the series","volume":"73","author":"European Association for the Study of the Liver","year":"2020","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.meegid.2024.105653_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028006","article-title":"HCV 6a prevalence in Guangdong province had the origin from Vietnam and recent dissemination to other regions of China: phylogeographic analyses","volume":"7","author":"Fu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2024.105653_bb0050","article-title":"Phylogenetic characterization of the 5\u2019 untranslated region of Untypable HCV genotypes circulating in Pakistan","volume":"1\u20136","author":"Ghani","year":"2020","journal-title":"Intervirology"},{"issue":"5","key":"10.1016\/j.meegid.2024.105653_bb0055","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3390\/v14050944","article-title":"Treatment response and drug resistance profiling of genotype 6 of hepatitis C virus in HCV\/HIV co-infected patients: a pilot study from INDIA","volume":"14","author":"Gupta","year":"2022","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.meegid.2024.105653_bb0060","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/jvh.12635","article-title":"Pan-genotypic treatment regimens for hepatitis C virus: advantages and disadvantages in high- and low-income regions","volume":"24","author":"H\u00e9zode","year":"2017","journal-title":"J. Viral Hepat."},{"issue":"5","key":"10.1016\/j.meegid.2024.105653_bb0065","article-title":"Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals","volume":"4","author":"Howe","year":"2022","journal-title":"JHEP Rep. Innovat. Hepatol."},{"key":"10.1016\/j.meegid.2024.105653_bb0070","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.virol.2018.01.015","article-title":"Molecular evolution of hepatitis C virus in China: a nationwide study","volume":"516","author":"Huang","year":"2018","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.meegid.2024.105653_bb0080","doi-asserted-by":"crossref","first-page":"E30","DOI":"10.1111\/j.1469-0691.2011.03665.x","article-title":"High genetic diversity including potential new subtypes of hepatitis C virus genotype 6 in Lao People\u2019s Democratic Republic","volume":"17","author":"Hubschen","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.meegid.2024.105653_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104871","article-title":"Molecular characterization of hepatitis C virus for subtype determination and resistance-associated substitutions detection among Chinese voluntary blood donors","volume":"181","author":"Jiang","year":"2020","journal-title":"Antivir. Res."},{"issue":"5","key":"10.1016\/j.meegid.2024.105653_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155869","article-title":"Geno2pheno[HCV] - a web-based interpretation system to support hepatitis C treatment decisions in the era of direct-acting antiviral agents","volume":"11","author":"Kalaghatgi","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.meegid.2024.105653_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082304","article-title":"Molecular epidemiologic characterization of a clustering HCV infection caused by inappropriate medical care in Heyuan City of Guangdong, China","volume":"8","author":"Kuang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2024.105653_bb0110","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2147\/IDR.S146595","article-title":"Prevalence of hepatitis C virus-resistant association substitutions to direct-acting antiviral agents in treatment-na\u00efve hepatitis C genotype 1b-infected patients in western China","volume":"10","author":"Li","year":"2017","journal-title":"Infect. Drug Resist."},{"issue":"2","key":"10.1016\/j.meegid.2024.105653_bb0115","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11262-016-1420-0","article-title":"Assessment of HCV genotypes in Yunnan Province of Southwest China","volume":"53","author":"Li","year":"2017","journal-title":"Virus Genes"},{"issue":"06","key":"10.1016\/j.meegid.2024.105653_bb0120","first-page":"634","article-title":"Hepatitis C case report and sentinel surveillance in China from 2015 to 2021","volume":"29","author":"Li","year":"2023","journal-title":"Chin. J. Aids. Std."},{"issue":"2","key":"10.1016\/j.meegid.2024.105653_bb0125","article-title":"Phylogenetic signature and prevalence of natural resistance-associated substitutions for hepatitis C virus genotypes 3a and 3b in southwestern China","volume":"8","author":"Liu","year":"2022","journal-title":"J. Virus Erad."},{"key":"10.1016\/j.meegid.2024.105653_bb0130","first-page":"167","article-title":"Hepatitis C virus RNA replication","volume":"369","author":"Lohmann","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"4","key":"10.1016\/j.meegid.2024.105653_bb0135","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/jmv.20307","article-title":"Hepatitis C virus genotype distribution in China: predominance of closely related subtype 1b isolates and existence of new genotype 6 variants","volume":"75","author":"Lu","year":"2005","journal-title":"J. Med. Virol."},{"issue":"Pt 3","key":"10.1016\/j.meegid.2024.105653_bb0140","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1099\/vir.0.81400-0","article-title":"Hepatitis C virus complete genome sequences identified from China representing subtypes 6k and 6n and a novel, as yet unassigned subtype within genotype 6","volume":"87","author":"Lu","year":"2006","journal-title":"J. Gen. Virol."},{"issue":"13","key":"10.1016\/j.meegid.2024.105653_bb0145","doi-asserted-by":"crossref","first-page":"7120","DOI":"10.1128\/JVI.00414-14","article-title":"Migration patterns of hepatitis C virus in China characterized for five major subtypes based on samples from 411 volunteer blood donors from 17 provinces and municipalities","volume":"88","author":"Lu","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2024.105653_bb0150","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3389\/fmicb.2019.00535","article-title":"Subtype-specific prevalence of hepatitis C virus NS5A resistance associated substitutions in mainland China","volume":"10","author":"Lu","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.meegid.2024.105653_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.894460","article-title":"Emergence and persistence of resistance-associated substitutions in HCV GT3 patients failing direct-acting antivirals","volume":"13","author":"Mushtaq","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.meegid.2024.105653_bb0160","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.gastro.2016.04.003","article-title":"Hepatitis C virus resistance to direct-acting antiviral drugs in interferon-free regimens","volume":"151","author":"Pawlotsky","year":"2016","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.meegid.2024.105653_bb0165","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1053\/j.gastro.2018.02.017","article-title":"HCV genotype 6a escape from and resistance to Velpatasvir, Pibrentasvir, and Sofosbuvir in robust infectious cell culture models","volume":"154","author":"Pham","year":"2018","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.meegid.2024.105653_bb0170","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"8\u20139","key":"10.1016\/j.meegid.2024.105653_bb0175","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ijpara.2007.04.009","article-title":"Investigating the endemic transmission of the hepatitis C virus","volume":"37","author":"Pybus","year":"2007","journal-title":"Int. J. Parasitol."},{"issue":"2","key":"10.1016\/j.meegid.2024.105653_bb0180","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1128\/JVI.01501-08","article-title":"Genetic history of hepatitis C virus in East Asia","volume":"83","author":"Pybus","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2024.105653_bb0185","first-page":"57","article-title":"Transmission dynamics of hepatitis C virus among intra venous drug users in the border state of Manipur, India","volume":"24","author":"Saha","year":"2014","journal-title":"Infect. Genet. Evolut. J. Mol. Epidemiol. Evolut. Genetics Infect. Dis."},{"issue":"2","key":"10.1016\/j.meegid.2024.105653_bb0190","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jhep.2015.09.011","article-title":"The importance of resistance to direct antiviral drugs in HCV infection in clinical practice","volume":"64","author":"Sarrazin","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.meegid.2024.105653_bb0195","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.antiviral.2015.01.003","article-title":"Prevalence of the hepatitis C virus NS3 polymorphism Q80K in genotype 1 patients in the European region","volume":"116","author":"Sarrazin","year":"2015","journal-title":"Antivir. Res."},{"issue":"4","key":"10.1016\/j.meegid.2024.105653_bb0200","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/hep.20819","article-title":"Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes","volume":"42","author":"Simmonds","year":"2005","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"5","key":"10.1016\/j.meegid.2024.105653_bb0205","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/hep.29837","article-title":"Resistance analysis of genotype 3 hepatitis C virus indicates subtypes inherently resistant to nonstructural protein 5A inhibitors","volume":"69","author":"Smith","year":"2019","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"12","key":"10.1016\/j.meegid.2024.105653_bb0210","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/cid\/ciu697","article-title":"Infrequent development of resistance in genotype 1-6 hepatitis C virus-infected subjects treated with sofosbuvir in phase 2 and 3 clinical trials","volume":"59","author":"Svarovskaia","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.meegid.2024.105653_bb0215","doi-asserted-by":"crossref","first-page":"a037093","DOI":"10.1101\/cshperspect.a037093","article-title":"Hepatitis C virus replication","volume":"10","author":"Tabata","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"23","key":"10.1016\/j.meegid.2024.105653_bb0220","doi-asserted-by":"crossref","first-page":"11022","DOI":"10.1073\/pnas.91.23.11022","article-title":"Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups","volume":"91","author":"Tokita","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.meegid.2024.105653_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163062","article-title":"HCV diversity among Chinese and Burmese IDUs in Dehong, Yunnan, China","volume":"11","author":"Wan","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.meegid.2024.105653_bb0230","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jcv.2008.12.009","article-title":"A new HCV genotype 6 subtype designated 6v was confirmed with three complete genome sequences","volume":"44","author":"Wang","year":"2009","journal-title":"J. Clin. Virol. Off. Pub. Pan Am. Soc. Clin. Virol."},{"key":"10.1016\/j.meegid.2024.105653_bb0235","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.antiviral.2018.08.001","article-title":"HCV phylogenetic signature and prevalence of pretreatment NS5A and NS5B NI-resistance associated substitutions in HCV-infected patients in mainland China","volume":"158","author":"Wei","year":"2018","journal-title":"Antivir. Res."},{"issue":"2","key":"10.1016\/j.meegid.2024.105653_bb0240","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S2468-1253(18)30343-1","article-title":"Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial","volume":"4","author":"Wei","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.meegid.2024.105653_bb0245","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.2147\/IDR.S218584","article-title":"Computational analysis of naturally occurring resistance-associated substitutions in genes NS3, NS5A, and NS5B among 86 subtypes of hepatitis C virus worldwide","volume":"12","author":"Wu","year":"2019","journal-title":"Infect. Drug Resist."},{"issue":"3","key":"10.1016\/j.meegid.2024.105653_bb0250","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3851\/IMP3181","article-title":"Long-term persistence of HCV NS5A resistance-associated substitutions after treatment with the HCV NS5A inhibitor, ledipasvir, without sofosbuvir","volume":"23","author":"Wyles","year":"2018","journal-title":"Antivir. Ther."},{"issue":"05","key":"10.1016\/j.meegid.2024.105653_bb0255","first-page":"755","article-title":"Genotype distribution of 1 998 strains of hepatitis C virus in West China hospital of Sichuan university from 2009 to 2013","volume":"47","author":"Xiao","year":"2016","journal-title":"J. Sichuan Univ. (Med Sci Edi)"},{"issue":"7","key":"10.1016\/j.meegid.2024.105653_bb0260","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3851\/IMP3149","article-title":"In vitro selection of resistance to sofosbuvir in HCV replicons of genotype-1 to \u22126","volume":"22","author":"Xu","year":"2017","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.meegid.2024.105653_bb0265","first-page":"139","article-title":"Complicated HCV subtype expansion among drug users in Guangdong province, China","volume":"73","author":"Yan","year":"2019","journal-title":"Infect. Genet. Evol. J. Mol. Epidemiol. Evolut. Genet. Infect. Dis."},{"issue":"5","key":"10.1016\/j.meegid.2024.105653_bb0270","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jhep.2017.01.007","article-title":"NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: prevalence and effect on treatment outcome","volume":"66","author":"Zeuzem","year":"2017","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.meegid.2024.105653_bb0275","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/jvh.12677","article-title":"Population dynamics of hepatitis C virus subtypes in injecting drug users on methadone maintenance treatment in China associated with economic and health reform","volume":"24","author":"Zhou","year":"2017","journal-title":"J. Viral Hepat."}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134824001047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134824001047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T20:11:27Z","timestamp":1725394287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134824001047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":52,"alternative-id":["S1567134824001047"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2024.105653","relation":{},"ISSN":["1567-1348"],"issn-type":[{"value":"1567-1348","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C virus subtype distribution and resistance-associated substitutions in high-risk population groups in Guangdong Province, China","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2024.105653","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105653"}}